Galderma R&D

This study tests a drug called nemolizumab in toddlers aged 6 to 23 months with moderate-to-severe atopic dermatitis (eczema) that hasn't improved with creams or ointments. The goal is to see how the drug moves through the body, if it is safe, and if it helps control the conditio…

This study tests a drug called nemolizumab in 162 adults with systemic sclerosis, a disease that causes skin thickening and can harm internal organs. Participants receive either nemolizumab or a placebo as a shot under the skin for 52 weeks. The main goal is to see if the drug re…

This study is tracking 1,000 adolescents and adults with moderate-to-severe atopic dermatitis (eczema) who are starting treatment with nemolizumab (Nemluvio®) in real-world clinics. The main goal is to see how well the drug controls skin symptoms and itching after 6 months, using…

This study looks at how well the drug nemolizumab works for adults with moderate-to-severe prurigo nodularis, a skin condition that causes intense itching and bumps. Researchers will track 600 participants over 6 months in real-world clinics, measuring itch severity and skin lesi…

This study looks at the safety of using Restylane Lyft with Lidocaine, a hyaluronic acid gel, for a second treatment to improve the chin profile. About 100 adults aged 22 and older will receive the retreatment. The main goal is to track any side effects related to the gel or inje…

This study tests Sculptra injections to improve cheek wrinkles and skin looseness in 25 women aged 45-65. Participants receive up to three treatments, and researchers use special cameras to measure skin changes over time. The goal is to see if this cosmetic procedure works and ho…

This study looks at how a treatment called poly L-lactic acid (PLLA) changes proteins in the skin of menopausal women with cheek wrinkles. About 40 women will receive the treatment, and small skin samples will be taken to measure these changes. The goal is to understand how the t…